Range Cancer Therapeutics ETF (CNCR)
NASDAQ: CNCR · Real-Time Price · USD
14.15
-0.23 (-1.60%)
Dec 3, 2024, 4:00 PM EST - Market closed
CNCR Holdings List
As of Nov 27, 2024
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | RXRX | Recursion Pharmaceuticals, Inc. | 2.75% |
2 | GLUE | Monte Rosa Therapeutics, Inc. | 2.30% |
3 | IBRX | ImmunityBio, Inc. | 2.07% |
4 | REPL | Replimune Group, Inc. | 1.91% |
5 | DNA | Ginkgo Bioworks Holdings, Inc. | 1.88% |
6 | RVMD | Revolution Medicines, Inc. | 1.87% |
7 | EXEL | Exelixis, Inc. | 1.86% |
8 | XNCR | Xencor, Inc. | 1.72% |
9 | BMY | Bristol-Myers Squibb Company | 1.68% |
10 | SWTX | SpringWorks Therapeutics, Inc. | 1.67% |
11 | ACLX | Arcellx, Inc. | 1.64% |
12 | ZYME | Zymeworks Inc. | 1.64% |
13 | ELVN | Enliven Therapeutics, Inc. | 1.61% |
14 | HCM | HUTCHMED (China) Limited | 1.58% |
15 | KPTI | Karyopharm Therapeutics Inc. | 1.58% |
16 | MRSN | Mersana Therapeutics, Inc. | 1.58% |
17 | SDGR | Schrödinger, Inc. | 1.57% |
18 | BPMC | Blueprint Medicines Corporation | 1.56% |
19 | CRBU | Caribou Biosciences, Inc. | 1.54% |
20 | MGNX | MacroGenics, Inc. | 1.51% |
21 | GNLX | Genelux Corporation | 1.50% |
22 | ERAS | Erasca, Inc. | 1.47% |
23 | ARVN | Arvinas, Inc. | 1.47% |
24 | DAWN | Day One Biopharmaceuticals, Inc. | 1.43% |
25 | RPTX | Repare Therapeutics Inc. | 1.42% |
26 | IMCR | Immunocore Holdings plc | 1.41% |
27 | ZNTL | Zentalis Pharmaceuticals, Inc. | 1.40% |
28 | BNTX | BioNTech SE | 1.39% |
29 | KYMR | Kymera Therapeutics, Inc. | 1.37% |
30 | IOVA | Iovance Biotherapeutics, Inc. | 1.36% |
31 | GERN | Geron Corporation | 1.35% |
32 | NUVB | Nuvation Bio Inc. | 1.34% |
33 | RCUS | Arcus Biosciences, Inc. | 1.33% |
34 | JANX | Janux Therapeutics, Inc. | 1.32% |
35 | ACRV | Acrivon Therapeutics, Inc. | 1.30% |
36 | YMAB | Y-mAbs Therapeutics, Inc. | 1.30% |
37 | CMPX | Compass Therapeutics, Inc. | 1.30% |
38 | PGEN | Precigen, Inc. | 1.29% |
39 | SNDX | Syndax Pharmaceuticals, Inc. | 1.29% |
40 | ALLO | Allogene Therapeutics, Inc. | 1.29% |
41 | AURA | Aura Biosciences, Inc. | 1.28% |
42 | INBX | Inhibrx Biosciences, Inc. | 1.27% |
43 | MRUS | Merus N.V. | 1.27% |
44 | BMEA | Biomea Fusion, Inc. | 1.25% |
45 | MRK | Merck & Co., Inc. | 1.24% |
46 | NUVL | Nuvalent, Inc. | 1.22% |
47 | FHTX | Foghorn Therapeutics Inc. | 1.19% |
48 | LEGN | Legend Biotech Corporation | 1.19% |
49 | NRIX | Nurix Therapeutics, Inc. | 1.18% |
50 | TSVT | 2seventy bio, Inc. | 1.17% |
As of Nov 27, 2024